Unaltered dopaminergic modulation of XXXX secretion in @entity82 .

@entity1 @entity82 @entity1369 @entity843 @entity1372 @entity1769 @entity916
1. The responses of plasma @entity1369 and plasma prolactin concentrations to @entity1769 (10 mg intravenously) were evaluated over 2 h in eight healthy controls and in 23 @entity1 with @entity82 (10 without and 13 with @entity843 ). Plasma @entity916 activity, glomerular filtration rate and renal @entity1372 excretion were also determined. 2. @entity1769 did not significantly influence plasma @entity916 activity, whereas both plasma @entity1369 and plasma prolactin rose significantly. The incremental areas under the curves did not differ among controls and cirrhotic @entity1 without and with @entity843 . No significant correlations between plasma prolactin and @entity1369 , either under basal conditions or after @entity1769 administration, were found in either controls or @entity1 . 3. Glomerular filtration rate did not change after @entity1769 . Renal @entity1372 excretion in controls and cirrhotic @entity1 without @entity843 was also unaffected, whereas it decreased significantly in cirrhotic @entity1 with @entity843 . In the latter, renal @entity1372 excretion was inversely correlated with plasma @entity1369 both under basal conditions and after @entity1769 administration. 4. The dopaminergic control of @entity1369 secretion does not appear to be significantly altered in @entity82 . @entity1769 administration to cirrhotic @entity1 with @entity843 leads to an increase in plasma @entity1369 that may enhance renal @entity1372 retention.
